Page 144 - CW E-Magazine (30-7-2024)

Pharmaceuticals

PROGRESSIVE AMENDMENT
Animal protection body welcomes IPC’s move to

waive off animal testing for veterinary vaccines

The Indian chapter of animal affi rms India’s commitment towards
protection organisation, Humane eliminating obsolete animal tests for
Society International (HSI/India), has batch release testing of vaccines. We
welcomed the Indian Pharmacopoeia have been working on this with both
Commission’s (IPC’s) move to waive IPC and the industry since 2020 and
off the Target Animal Batch Safety we believe that such collaboration is
Test (TABST) in the Indian Pharma- pivotal in this decision. We look for-
copoeia, effective 1st July 2024. ward to facilitating further advance-
ments in other areas of safety testing
The TABST, a non-specific safety of vaccines as well.”
test for veterinary vaccines, typi- testing. By recognising the shortfalls
cally involves the administration of of the TABST and allowing the test This waiver follows a series of pro-
vaccine overdose to animals to test to be waived, India is a step closer gressive decisions by the IPC. Back in
that every batch of vaccine produced to aligning itself with international 2018, the Rabbit Pyrogen Test was
is safe for a specific species. How- veterinary vaccine testing standards, replaced with the Bacterial Endotoxin
ever, multiple studies have proved joining Brazil, Europe, Canada, the Test (BET), followed by the inclu-
that the method lacks specificity US, Japan, and others,” HSI/India sion of the Monocyte Activation Test
and is prone to producing false re- said in a statement. in 2018 and removal of the Abnormal
sults. “The IPC’s decision to waive Toxicity Test for almost all human
the TABST will reduce the number Ms. Alokparna Sengupta, Man- vaccines in 2020 from Indian Pharma-
of animals subjected to unnecessary aging Director at HSI/India said, “re- copoeia monographs.
Suraj Laboratories’ R&D facility gets DSIR

recognition

Hyderabad-based pharma fi rm,
Suraj Laboratories, has announced
that its in-house R&D unit located in
Hyderabad (Telangana) has received
prestigious recognition from the
Department of Scientifi c and Industrial
Research (DSIR), Ministry of Science
and Technology.

The recognition will entitle the
R&D unit to avail customs/central innovative work, including development at Kadechur, Karnataka. “The collabo-
excise duty exemption on the purchase/ of new products, design and engineer- ration between Lamoral and Neochem
import of equipment, instruments, ing, and process/product/design im- Technologies represents a powerful syn-
spares, consumables etc for its activi- provements. ergy. By combining Lamoral’s innova-
ties. The registration is valid up to 31 tion, global reach and technical prowess
March 2027, the company informed. Suraj Laboratories, which offers with Neochem’s agility, local expertise
generic Active Pharmaceutical Ingredients and innovative spirit, we aim to create
The DSIR recognition is accord- (APIs) and saleable intermediates for unparalleled value for our customers and
ed to in-house R&D units engaged in APIs, operates a manufacturing plant partners,” the press note informed.

144 Chemical Weekly July 30, 2024

Contents Index to Advertisers Index to Products Advertised